Raymond James & Associates Xencor Inc Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in Xencor Inc stock. As of the latest transaction made, Raymond James & Associates holds 10,776 shares of XNCR stock, worth $203,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,776Holding current value
$203,989% of portfolio
0.0%Shares
8 transactions
Others Institutions Holding XNCR
# of Institutions
203Shares Held
64MCall Options Held
2.2KPut Options Held
1.3K-
Black Rock Inc. New York, NY11.1MShares$209 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA9.09MShares$172 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.01MShares$133 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.33MShares$101 Million3.36% of portfolio
-
State Street Corp Boston, MA4.24MShares$80.2 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $1.13B
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...